2.Asia's first successful minimally invasive transapical transcatheter mitral valve-in-valve implantation.
Jia Lin SOON ; Yeow Leng CHUA ; Victor Tt CHAO ; Paul Tl CHIAM ; See Hooi EWE ; Ving Yuen SEETHO ; Chung Yin LEE ; Swee Yaw TAN ; Tian Hai KOH ; Kenny Yk SIN
Annals of the Academy of Medicine, Singapore 2013;42(2):85-87
3.Comparison of the Haemodynamic Parameters of Venous and Arterial Coronary Artery Bypass Conduits.
Jun Mei ZHANG ; Clement Jh CHAN ; Ning KANG ; Jia Lin SOON ; Kenny Yk SIN ; Victor Tt CHAO ; Teing Ee TAN ; Chong Hee LIM ; Mathew J CHAKARAMAKKIL ; Adrian Sw OOI ; Yeow Leng CHUA ; Ru San TAN ; Liang ZHONG
Annals of the Academy of Medicine, Singapore 2016;45(8):369-372
Aged
;
Atherosclerosis
;
Case-Control Studies
;
Coronary Artery Bypass
;
methods
;
Coronary Artery Disease
;
surgery
;
Female
;
Hemodynamics
;
physiology
;
Humans
;
Male
;
Mammary Arteries
;
physiology
;
transplantation
;
Middle Aged
;
Pulsatile Flow
;
Radial Artery
;
physiology
;
transplantation
;
Rheology
;
Saphenous Vein
;
physiology
;
transplantation
;
Shear Strength
;
Stress, Mechanical
;
Vascular Patency
;
physiology
4.Percutaneous transcatheter aortic valve implantation for degenerated surgical bioprostheses: the first case series in Asia with one-year follow-up.
Paul Toon-Lim CHIAM ; See-Hooi EWE ; Jia-Lin SOON ; Kay-Woon HO ; Yong-Koong SIN ; Swee-Yaw TAN ; Soo-Teik LIM ; Tian-Hai KOH ; Yeow-Leng CHUA
Singapore medical journal 2016;57(7):401-405
INTRODUCTIONPercutaneous transcatheter aortic valve implantation (TAVI) has become an established therapy for inoperable and high-surgical-risk patients with severe aortic stenosis. Although TAVI in patients with degenerated surgical aortic bioprostheses (i.e. valve-in-valve TAVI) is increasingly reported in Western studies, such data is lacking in Asian patients. We describe the initial experience of valve-in-valve TAVI in Asia.
METHODSEight patients who underwent valve-in-valve TAVI due to degenerated aortic bioprostheses were enrolled. The mechanism of bioprosthetic valve failure was stenotic, regurgitation or mixed. All procedures were performed via transfemoral arterial access, using the self-expanding CoreValve prosthesis or balloon-expandable SAPIEN XT prosthesis.
RESULTSThe mean age of the patients was 71.6 ± 13.2 years and five were male. Mean duration to surgical bioprosthesis degeneration was 10.2 ± 4.1 years. Valve-in-valve TAVI was successfully performed in all patients. CoreValve and SAPIEN XT prostheses were used in six and two patients, respectively. There were no deaths, strokes or permanent pacemaker requirement at 30 days, with one noncardiac mortality at one year. All patients experienced New York Heart Association functional class improvement. Post-procedure mean pressure gradients were 20 ± 11 mmHg and 22 ± 8 mmHg at 30 days and one year, respectively. Residual aortic regurgitation (AR) of more than mild severity occurred in one patient at 30 days. At one year, only one patient had mild residual AR.
CONCLUSIONIn our experience of valve-in-valve TAVI, procedural success was achieved in all patients without adverse events at 30 days. Good clinical and haemodynamic outcomes were sustained at one year.
Aged ; Aged, 80 and over ; Aortic Valve ; surgery ; Aortic Valve Insufficiency ; surgery ; Aortic Valve Stenosis ; surgery ; Arteries ; Bioprosthesis ; Cardiac Catheterization ; methods ; Female ; Fluoroscopy ; Follow-Up Studies ; Heart Valve Prosthesis ; Heart Valve Prosthesis Implantation ; Hemodynamics ; Humans ; Male ; Middle Aged ; Pacemaker, Artificial ; Prosthesis Failure ; Severity of Illness Index ; Transcatheter Aortic Valve Replacement
5.Safety, tolerability and efficacy of LEGA-Kid® mechanical percussion device versus conventional chest physiotherapy in children: a randomised, single-blind controlled study.
Yuen Ling HUE ; Lucy Chai See LUM ; Siti Hawa AHMAD ; Soon Sin TAN ; Shin Yee WONG ; Anna Marie NATHAN ; Kah Peng EG ; Melissa de Bruyne Ming May CHOON
Singapore medical journal 2022;63(2):105-110
INTRODUCTION:
Chest physiotherapy (CPT) may benefit children aged below five years who suffer from lower respiratory tract infection (LRTI). However, its effects depend on the technique used. This study aimed to determine whether mechanical CPT using the LEGA-Kid® mechanical percussion device is superior to manual CPT in children with LRTI.
METHODS:
Children aged five months to five years who were admitted and referred for CPT from January to April 2017 were randomised to either manual CPT or mechanical CPT with LEGA-Kid. Outcomes measured before intervention and two hours after intervention were respiratory rate (RR), oxygen saturation and modified Respiratory Distress Assessment Instrument (mRDAI) score.
RESULTS:
All 30 enrolled patients showed significant reduction in post-intervention RR and mRDAI scores. There was an 8% reduction in RR for the manual CPT group (p = 0.002) and a 16.5% reduction in the mechanical CPT group (p = 0.0001), with a significantly greater reduction in the latter (p = 0.024). mRDAI scores decreased by 2.96 in the manual group (p = 0.0001) and 3.62 in the mechanical group (p = 0.002), with no significant difference between the groups. There was no significant improvement in oxygen saturation, and no adverse events were observed after CPT.
CONCLUSION
Children receiving both manual and mechanical CPT showed improvements in respiratory distress symptoms, with no adverse effects. A combined strategy of nebulised hypertonic saline followed by CPT for LRTI removes airway secretions and results in improvements in moderately severe respiratory distress. The LEGA-Kid mechanical CPT method is superior to manual CPT in reducing the RR.
Child
;
Humans
;
Percussion/methods*
;
Physical Therapy Modalities
;
Respiratory Distress Syndrome
;
Respiratory Therapy/methods*
;
Respiratory Tract Infections
;
Single-Blind Method
6.Intermittent EGFR-TKI Therapy is Associated with Durable Response in Advanced EGFR-Mutant NSCLC: A Case Report
Sin Nee Tan ; Aishah Ibrahim ; Megat Razeem Abdul Razak ; Muhammad Naimmuddin Abdul Azih ; Soon Hin How
Malaysian Journal of Medicine and Health Sciences 2023;19(No.2):341-343
Madam S, who diagnosed to have stage IV lung adenocarcinoma with exon 21 L858R point mutation (T3N2M1a)
was admitted for massive pericardial effusion in April 2016. She was ECOG 4 on admission. Her ECOG improved
to 1 after pericardial tapping and initiation of free sample erlotinib 100 mg daily. Repeated CT thorax post treatment
showed the disease was partial responded. Due to financial constraints, she had never bought any EGFR-TKI. She
was given a free sample of erlotinib intermittently for total of 12 months followed by intermittent afatinib supply for
2 years. Due to this limited supply, she took half doses of afatinib by cutting a 40 mg tablet once every few days to
sustain the continuation of cancer treatment. No major side effects were observed and she remained ECOG 0 with
good weight gain. Up to her last clinic visit in September 2021, her PFS was more than 5 years. Intermittent doses of
EGFR-TKI may prolong PFS in patients with advanced EGFRm+ NSCLC who has limited treatment options.